Pietro Maria Stefani

BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients

Giuseppe Visani, Lara Malerba, Pietro Maria Stefani et al. · Blood · 2011 · 135 citations · Full text

Advanced mast cell disease: an Italian Hematological Multicenter experience

Livio Pagano, Caterina Giovanna Valentini, Morena Caira et al. · International Journal of Hematology · 2008 · 47 citations · Full text

Mast Cell Disorder, Immunology, Hematology +3

A Novel High Dose Chemotherapy Strategy with Bendamustine In Adjunct to Etoposide, Cytarabine and Melphalan (BeEAM) Followed by Autologous Stem Cell Rescue Is Safe and Highly Effective for the Treatment of Resistant/Relapsed Lymphoma Patients: a Phase I-II Study on 44 Patients

Giuseppe Visani, Lara Malerba, Pietro Maria Stefani et al. · Blood · 2010 · 14 citations

Comprehensive Minimal Residual Disease (MRD) Analysis of the Fondazione Italiana Linfomi (FIL) MCL0208 Clinical Trial for Younger Patients with Mantle Cell Lymphoma: A Kinetic Model Ensures a More Refined Risk Stratification

Simone Ferrero, Daniela Barbero, Mariella Lo Schirico et al. · Blood · 2018 · 10 citations